Carl Zeiss Honors EuroEyes International for Exceptional Milestone in AT LISA® Trifocal Lens Implantations, the Aging Population Fuels Growing Demand for Presbyopia Correction Surgery: An Opportunity-Rich Market to Seize

EuroEyes 2024 Interim Revenue Reaches Record High of HK$368mn, Resilient Demand for Presbyopia Correction Surgery Fuels Future Growth

EuroEyes 2023 Annual Revenue and EBITDA Reach New Highs, Continued Expansion to Achieve Organic Growth and Meet 2026 Targets

EuroEyes Celebrates Grand Opening of Flagship Clinic across from Luxury Shopping Centre, Times Square, Hong Kong

EuroEyes Announces 2023 Interim Results

EuroEyes to Acquire 100% Equity Interest in FreeVis GmbH